Nanomedicine: Nanotechnology, Biology and Medicine
Volume 8, Issue 2 , Pages 185-193 , February 2012

Novel nanostructured lipid-dextran sulfate hybrid carriers overcome tumor multidrug resistance of mitoxantrone hydrochloride

  • Peng Zhang, PhD

      Affiliations

    • School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
    • ,
  • Guixia Ling, PhD

      Affiliations

    • School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
    • ,
  • Xiaolei Pan, MS

      Affiliations

    • School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
    • ,
  • Jin Sun, PhD

      Affiliations

    • School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
    • ,
  • Tianhong Zhang, PhD

      Affiliations

    • School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
    • ,
  • Xiaohui Pu, PhD

      Affiliations

    • School of Pharmacy, Henan University, Kaifeng, China
    • ,
  • Shiliang Yin, PhD

      Affiliations

    • School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
    • ,
  • Zhonggui He, PhD

      Affiliations

    • School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
    • Corresponding Author InformationCorresponding author: School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China.

Received 3 March 2011 ,Accepted 7 June 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The work was supported by the National Basic Research Program of China (973 Program), No. 2009CB930300, and Key Project for Drug Innovation (2008ZX09401-004) from the Ministry of Science and Technology of China.

PII: S1549-9634(11)00260-7

doi: 10.1016/j.nano.2011.06.007

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 8, Issue 2 , Pages 185-193 , February 2012

Article Tools

* Image Usage & Resolution